ArticleOpen heart2025
Prominent V waves in right heart catheterisation as a marker of left atrial stiffness in pulmonary hypertension.
Article in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionStiff left atrium (LA) is important in the pathophysiology and progression of heart failure with preserved ejection fraction. Non-invasive techniques used to measure stiff LA have significant limitations. Prominent V waves seen during right heart catheterisation (RHC) have been linked to a stiff LA; however, there are no studies exploring the prevalence of this in patients with pulmonary hypertension (PH). We present the first study assessing stiff LA using invasive techniques in patients with PH using V wave measurements on RHC.
methods50 patients with PH (66.9±14.5 years, 30% male) and 18 controls were studied. Patients with left ventricular (LV) dysfunction, moderate or greater mitral regurgitation or atrial fibrillation were excluded. Echocardiographic (LA area, E/E' average, LV hypertrophy) and RHC (peak/mean pulmonary artery pressures, mean pulmonary capillary wedge pressure (mPCWP), V wave) parameters were collected. Prominent V wave was defined as ≥10 mm Hg above mPCWP. Prevalence of prominent V waves and its correlations between echocardiographic and RHC parameters were determined.
resultsSix (12%) patients with PH had prominent V waves, while none of the control patients did (12% vs 0%, respectively, p=0.18). Prominent V waves were only seen in patients with postcapillary PH (28.6% vs 0%; p=0.003) and were strongly associated with echocardiographic parameters-LA size and E/E' ratio.
conclusionsProminent V waves, a marker of stiff LA, can be easily and readily assessed by RHC and are common with postcapillary PH. Larger studies are needed to elucidate its clinical implications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.